Bellevue Asset Management AG
Bellevue Asset Management is an authorized asset manager of collective investment schemes subject to regulation by the Swiss Financial Market Supervisory Authority FINMA. As such, it is in compliance with all regulatory and legal requirements placed upon managers of collective investment schemes. Bellevue Asset Management is responsible for the operating activities of BB Biotech AG and for the investment management operations of the Bellevue Funds (Lux) SICAV and other investment funds and mandates.
Bellevue Asset Management boasts a highly specialized team of more than 35 experienced analysts, portfolio managers and product experts. Its expertise and investment focus lie in the healthcare sector products successfully launched and managed since 1993 as well as in specific niche strategies for Swiss and European equities and so-called new markets.
The products and services offered by Bellevue Asset Management are tailored to the special needs of our intermediary and institutional clientele. Our broad expertise is channeled through accordingly diverse product forms and mandates.
Company headquarters are located in Kusnacht, near Zurich, Switzerland, but we also have offices to serve you in Germany, Austria and Luxembourg. Bellevue Asset Management AG is wholly owned by Bellevue Group, which is listed on the SIX Swiss Exchange.
|Téléphone||00 41 44 267 67 00|
|Autorité de tutelle||FINMA (Autorité fédérale de surveillance des marchés financiers)|
|Numéro d'agrément||- (depuis: -)|
|Activités||Domaines d'interventions||Principaux gérants|
Société de Gestion
SFAMA (Swiss Funds and Asset MAnagement Association)
Vous pouvez ajouter des fonds ou des indices au comparateur depuis de multiples endroits du site OPCVM360 :
- Soit à l'aide du bouton sur les fiches fonds et indices
- Soit à l'aide de case à cocher dans les résultats et listes (recherche multicritère, palmares des fonds, listes d'indices) :